Clinical trial
Intravitreal Bevacizumab for Age-Related Macular Degeneration
NCT00347165 · Asociación para Evitar la Ceguera en México, Other · Terminated
Key facts
| NCT number | NCT00347165 |
|---|---|
| Title | Intravitreal Bevacizumab for Age-Related Macular Degeneration |
| Official title | Intravitreal Bevacizumab Therapy for Neovascular Age-Related Macular Degeneration: A Pilot Study |
| Lead sponsor | Asociación para Evitar la Ceguera en México, Other |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Age Related Macular Degeneration |
| Intervention type | Drug |
| Interventions | bevacizumab intravitreal injection |
| Enrollment | 50 |
| Start date | Sep 1, 2005 |
| Primary completion | Jun 1, 2006 |
| Completion | Sep 1, 2006 |
| First posted | Jul 4, 2006 |
| Last update posted | May 30, 2024 |
| Countries | Mexico |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: